Loading company…
Nido Biosciences develops medicines for neurological diseases.
Nido Biosciences develops small molecules using induced pluripotent stem cells derived from patient neural cells. Its research focuses on biological modulators of neurodegenerative diseases. Founded in 2018, the company is based in Massachusetts, US. It raised USD 86.6 million in series B funding in May 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in